Isabelle Fau Email & Phone Number

Chatou, Fr

Rueil Malmaison

Angelini Pharma – Creation of a cluster France BeneLuxHead of Market Affairs and Public Affairs – 2021 I was responsible of the launch of ONTOZRY (CNS) in France, Netherland, Belgium and Luxemburg. I had to develop and implement effective market access strategy to secure and maintain optimal price and reimbursement. I have to synthesize actionable payer insights; develop the access strategy and tactical plans and collaborate on the pricing strategy with Global Pricing Lead. Additional responsibilities included leading pricing negotiation with Health Authorities. Depending on country and Health Authority expectations health economic strategy and its execution has been performed (Netherland and Belgium). Results of the Health economic analysis have been disseminated to emphasize clinical benefits of ONTOZRY.As part of my role, I wrote the Early Access dossier in France and sat up co-paiement solution in Netherlands to secure access of ONTOZRY to patients. In order to provide better understanding of the epilepsy disease and the patient journey, I conducted real world evidence study. I lead Public Affairs Plan to install Angelini as a reliable and long term partner with dedicated actions to Government and key stakeholders.This is a highly collaborative role that must work cohesively with medical, regulatory and commercial team at local and Global level.

23 Rue Balzac 75017 Paris

SGE Consulting /2018 – 2021Director Economic Affairs & Market Access, MedTech – Diagnostic Test – AI – DigitalI was responsible of a team of 7 FTEs, junior and senior to drive and execute market access strategy in very divers area and major innovative products. Many market access strategies leads to recommend early access program like Article 51, Forfait Innovation.I was responsible to represent foreign companies (no local affiliates or distributors) and hold hearing at HAS and CEPS.I had important role in education and provided educational program on Market Access (Eura Santé, LS Leads) and prepare clinical experts for HAS hearing.I aimed to take over SGE Consulting and gathered investment funds to develop the expertise on innovative technologies and AI integrated solution.

Paris La Défense

Takeda / 2017- 2018Senior Market Access Lead, Myeloma, Lymphoma, NSCLC, Crohn diseaseI supervised the Market Access team (5 FTEs, including 2 new recruits). My responsibilities’ included leading the development of Market Access strategies and overseeing the teams’ execution for the launch of NINLARO, ALUNBRIG and ALOFISEL and the line extension for ADCETRIS. I established a strong collaboration beewteen local and Global Market Access and HEOR team to ensure pricing alignment and decisions during all the process of negotiation. I aimed to install regular meetings and worked cross functionally with medical, regulatory and commercial team.Partners with Global Market Access, HEOR, and other relevant functions so that pricing strategy and decisions follow international guidanceLed local cross functional team with medical, regulatory, marketing and commercial

Levallois

Lead the new role of Market Access, drive market access strategy and its execution for Astellas portfolio

Levallois

Managed 2 product managersLed the marketing strategy, developed and consolidated the marketing action plan

Paris La Défense

Led the strategy, implemented and coordinated action plan for Enbrel/Novatrex

Paris La Défense

Define and implement marketing strategy in line with International Marketing Lead

Paris La Défense

Define and implement marketing strategy

Master Of Business Administration (Mba), Management Marketing

Du Emaud, Market Access, Diplôme Universitaire

Maitrise De Sciences De Gestion, Economie, Gestion, Finance, Marketing, Maitrise

Du Medico-Economie, Medico-Economie, Mention Bien

Emaud, Market Access

Eumaud, Market Access